Sickle cell disease: role of reactive oxygen and nitrogen metabolites
- PMID: 17645642
- DOI: 10.1111/j.1440-1681.2007.04639.x
Sickle cell disease: role of reactive oxygen and nitrogen metabolites
Abstract
1. Sickle cell disease (SCD) is an inherited disorder of haemoglobin synthesis that is associated with significant morbidity and mortality due to sequelae of episodic vaso-occlusive events: pain crises and multiorgan damage. The microvascular responses to the initiation, progression and resolution of vaso-occlusive events are consistent with an inflammatory phenotype as suggested by activation of multiple cell types, an oxidatively stressed environment and endothelial cell dysfunction. 2. Decreased anti-oxidant defences in SCD patients and mice are accompanied by activation of enzymatic (NADPH oxidase, xanthine oxidase) and non-enzymatic (sickle haemoglobin auto-oxidation) sources of reactive oxygen species. The resultant oxidative stress leads to dysfunction/activation of arteriolar and venular endothelial cells, resulting in impaired vasomotor function and blood cell-endothelial cell adhesion. 3. Changes in substrate and cofactor availability for endothelial cell nitric oxide synthase may underlie reactive oxygen- and nitrogen-induced events that contribute to SCD-induced vasculopathy. 4. The emerging role of reactive oxygen and nitrogen species in the pathogenesis of SCD provides a platform for the development of novel agents to treat this painful and lethal disease.
Similar articles
-
Sickle cell disease vasculopathy: a state of nitric oxide resistance.Free Radic Biol Med. 2008 Apr 15;44(8):1506-28. doi: 10.1016/j.freeradbiomed.2008.01.008. Epub 2008 Jan 26. Free Radic Biol Med. 2008. PMID: 18261470 Review.
-
Sickle cell anemia and vascular dysfunction: the nitric oxide connection.J Cell Physiol. 2010 Sep;224(3):620-5. doi: 10.1002/jcp.22195. J Cell Physiol. 2010. PMID: 20578237 Review.
-
Role of oxidative stress in the pathogenesis of sickle cell disease.IUBMB Life. 2012 Jan;64(1):72-80. doi: 10.1002/iub.584. Epub 2011 Nov 30. IUBMB Life. 2012. PMID: 22131167 Review.
-
[Oxidant stress and endothelial dysfunction].Patol Fiziol Eksp Ter. 2005 Oct-Dec;(4):5-9. Patol Fiziol Eksp Ter. 2005. PMID: 16408656 Review. Russian. No abstract available.
-
Vascular NADPH oxidases as drug targets for novel antioxidant strategies.Drug Discov Today. 2006 Jun;11(11-12):524-33. doi: 10.1016/j.drudis.2006.04.003. Drug Discov Today. 2006. PMID: 16713904 Review.
Cited by
-
Mechanism of testosterone deficiency in the transgenic sickle cell mouse.PLoS One. 2015 May 29;10(5):e0128694. doi: 10.1371/journal.pone.0128694. eCollection 2015. PLoS One. 2015. PMID: 26023917 Free PMC article.
-
Optofluidic detection for cellular phenotyping.Lab Chip. 2012 Oct 7;12(19):3552-65. doi: 10.1039/c2lc40509a. Lab Chip. 2012. PMID: 22854915 Free PMC article. Review.
-
Prevalence of metabolic syndrome in sickle cell disease patients: A cross-sectional study at a tertiary hospital in Nepal.EJHaem. 2024 Aug 5;5(5):913-919. doi: 10.1002/jha2.989. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415909 Free PMC article.
-
Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.J Sex Med. 2012 Aug;9(8):1980-7. doi: 10.1111/j.1743-6109.2012.02798.x. Epub 2012 May 23. J Sex Med. 2012. PMID: 22620981 Free PMC article.
-
A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.Cardiovasc Hematol Disord Drug Targets. 2009 Dec;9(4):271-92. doi: 10.2174/1871529x10909040271. Cardiovasc Hematol Disord Drug Targets. 2009. PMID: 19751187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
